Fast Five Quiz: Atrial Fibrillation and Diabetes

Sandeep K. Goyal, MD


April 02, 2020

Researchers have demonstrated a dose-response relationship between circulating blood glucose levels and the development of AF. Thiazolidinedione use has been associated with a decreased risk of developing AF in patients with diabetes. Researchers have shown that better A1c control is associated with decreased thromboembolic risk. A recent study showed that AF is more common among persons with diabetic kidney disease.

Learn more about the relationship between blood glucose levels and AF risk.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.